title: Ibrutinib approved for the treatment of mantle cell lymphoma.
authors.forename: Stacey
authors.initials: S
authors.lastname: Small
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D017277:Drug Approval; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy*; D010880:Piperidines; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine